Geometric Antibody Engineering Reveals the Spatial Factor on the Efficacy of Bispecific T Cell Engagers
ACS Chemical Biology · 2024-04-19 · 19 (4) · 916-925
DOI: 10.1021/acschembio.3c00728 ↗At a glance
Journal article in ACS Chemical Biology, published online on 2024-03-16. Written by Yu Zhang and 9 co-authors. Institution: College of Future Technology, Institute of Molecular Medicine, National Biomedical Imaging Center, Beijing Key Laboratory of Cardiometabolic Molecula…. Major MEDLINE topics: Antibodies, Bispecific, T-Lymphocytes. Cited 8 times so far (Crossref); 59 references. Funded by: Boehringer Ingelheim.
Abstract (original language)
Bispecific antibodies (BsAbs) represent an emerging class of biologics that can recognize two different antigens or epitopes. T-cell engagers (TcEs) bind two targets in trans on the cell surface of the effector and target cell to induce proximal immune effects, opening exciting windows for immunotherapies. To date, the engineering of BsAbs has been mainly focused on tuning the molecular weight and valency. However, the effects of spatial factors on the biological functions of BsAbs have been less explored due to the lack of biochemical methods to precisely manipulate protein geometry. Here, we studied the geometric effects of the TcEs. First, by genetically inserting rigidly designed ankyrin repeat proteins into TcEs, we revealed that the efficacy progressively decreased as the spacer distance of the two binding domains increased. Then, we constructed 26 pairs of TcEs with the same size but varying orientations using click chemistry-mediated conjugation at different mutation sites. We found that linear ligation sites play a minor role in modulating cell-killing efficacy. Next, we rendered the TcEs' advanced topology by cyclization chemistry using the SpyTag/SpyCatcher pair or sortase ligation approaches. Cyclized TcEs were generally more potent than their linear counterparts. Particularly, sortase A cyclized TcEs, bearing a minimal tagging motif, exhibited better cell-killing efficacy in vitro and improved stability both in vitro and in vivo compared to the linear TcE. This work combines modern bioconjugation chemistry and protein engineering tools for antibody engineering, shedding light on the elusive spatial factors of BsAbs functionality.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- College of Future Technology, Institute of Molecular Medicine, National Biomedical Imaging Center, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University, Beijing 100871, China.
- Peking-Tsinghua Center for Life Science, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China.
- Department of Research Beyond Borders, Boehringer Ingelheim, Investment Co., Ltd., Beijing 100027, China.
- Department of Research Beyond Borders, Boehringer Ingelheim, Investment Co., Ltd., Shanghai 200040, China.
- Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States.
ORCID profiles: Yu Zhang, Zhixing Chen
Funding
- Boehringer Ingelheim
Cite
APA
Zhang, Y., Yang, Z., Saimi, D., Shen, X., Ye, J., Yu, B., Pefaur, N., Scheer, J. M., Nixon, A. E., & Chen, Z. (2024). Geometric Antibody Engineering Reveals the Spatial Factor on the Efficacy of Bispecific T Cell Engagers. ACS Chemical Biology, 19(4), 916-925. https://doi.org/10.1021/acschembio.3c00728
Vancouver
Zhang Y, Yang Z, Saimi D, Shen X, Ye J, Yu B, et al. Geometric Antibody Engineering Reveals the Spatial Factor on the Efficacy of Bispecific T Cell Engagers. ACS Chemical Biology. 2024;19(4):916-925. doi:10.1021/acschembio.3c00728
BibTeX
@article{Zhang2024,
author = {Zhang, Yu and Yang, Zhe and Saimi, Dilizhatai and Shen, Xiaowen and Ye, Junqing and Yu, Bingke and Pefaur, Noah and Scheer, Justin M and Nixon, Andrew E and Chen, Zhixing},
title = {Geometric Antibody Engineering Reveals the Spatial Factor on the Efficacy of Bispecific T Cell Engagers},
journal = {ACS Chemical Biology},
year = {2024},
volume = {19},
number = {4},
pages = {916--925},
doi = {10.1021/acschembio.3c00728}
}
EUVIMED